Up to this day, little is known whether the extent of brain damage in patients with SAH correlates with the degree neurogenic myocardial injury and neurogenic lung injury. This is a prospective observational study designed to asses relationship between catecholamine surge and development of myocardial and lung injury in subarachnoid haemorrhage patients.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
In-hospital death (number of patients)
Timeframe: 7 days
Number of Patients with elevation in hs-TnT levels
Timeframe: 7 days
Number of Patients with elevation in NT-proBNP levels
Timeframe: 7 days
Number of Patients with elevation in creatine kinase levels
Timeframe: 7 days
Number of Patients with elevation in creatine kinase MB levels
Timeframe: 7 days
Number of Patients with a decrease in Horowitz index
Timeframe: 7 days
Number of Patients with need of increased FiO2
Timeframe: 7 days
Number of Patients with need of increased PEEP values
Timeframe: 7 days
Number of Patients with need for the use of neuro-muscular blocking agents
Timeframe: 7 days